Working to grow the reach of its sickle cell disease medicine Adakveo, Novartis has more than just Pfizer’s Oxbryta to worry about. After a phase 3 trial …

Italian drugmaker Menarini has succeeded where European Big Pharmas have failed, pushing the first oral selective estrogen receptor degrader (SERD) to treat breast cancer across the …

Hundreds of manufacturing jobs are in limbo as Sanofi weighs operations at a pair of vaccine plants overseas, marking the latest in an onslaught of …

A federal appeals court panel has voted unanimously to dismiss Johnson & Johnson’s attempt to use the controversial Texas two-step strategy to resolve claims from …

Two Bristol Myers Squibb employees who were fired for refusing to be vaccinated and sued the company have agreed to settlements, court documents show. Jeremy …

In December, Sens. Elizabeth Warren, D-Massachusetts, and Peter Welch, D-Vermont, sent a letter to Pfizer admonishing the company for a proposed increase in the price of …

In a split showing for cancer powerhouse Merck, its immunotherapy Keytruda continued a losing streak in prostate cancer but chalked up a win to pressure an industry-first …

Vir Biotechnology is tapping a veteran pharma dealmaker—and one of 2021’s Fiercest Women in Life Sciences—to helm the ship as the company’s long-time captain George …

Abzena, a CDMO specializing in the development and manufacture of antibody-drug conjugates, has laid off 66 employees in San Diego, according to a Worker Adjustment …

The nonprofit public health advocacy group the Physicians Committee has issued a formal complaint over allegations that Novo Nordisk paid for a promotional segment on …